Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
941
-
942
-
943
-
944
-
945
-
946
PIN1 silencing leads to decreases in the protein levels of HIF-1α.
Published 2016“…HCT116 cells plated on the chamber slide were transfected PIN1 si-RNA or treated PiB and grown at 1% O<sub>2</sub> in a hypoxia chamber for additional 4 h. …”
-
947
-
948
-
949
-
950
-
951
-
952
-
953
-
954
-
955
-
956
-
957
Design of the D-trial.
Published 2024“…Empirical models for the relationships between the investigated plant traits and PD/DVP were created using linear regression analysis preceded by a lack-of-fit test. An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
-
958
-
959
-
960
High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma.
Published 2017“…Total score across the six cell lines was calculated out of 6. (D) IC<sub>50</sub> measurements were calculated for drug screen hits quisinostat (HDAC inhibitor), BGT-226 (PI3K/mTOR inhibitor), bortezomib (proteasome inhibitor) as compared with the current standard for synovial sarcoma treatment doxorubicin (cytotoxic DNA/RNA intercalating agent and topoisomerase inhibitor), in a panel of six human SS18-SSX positive cell lines and two control cell lines (HEK293T, MCF7). …”